DKP: Direct Kernel Perceptron for the building of chemogenomics models

The project pursuits the application of the Direct Kernel Perceptron (DKP) for the building of chemogenomics models for prediction of compound activity and toxicity in collaboration with Janssen-Cilag, a subsidiary of the Johnson & Johnson Pharmaceutical Company.

Objectives

The project pursuits the application of the Direct Kernel Perceptron (DKP) for the building of chemogenomics models for prediction of compound activity and toxicity in collaboration with Janssen-Cilag, a subsidiary of the Johnson & Johnson Pharmaceutical Company.